HO-1 expression in type II pneumocytes after transpulmonary gene delivery

Citation
Yh. Weng et al., HO-1 expression in type II pneumocytes after transpulmonary gene delivery, AM J P-LUNG, 278(6), 2000, pp. L1273-L1279
Citations number
30
Categorie Soggetti
da verificare
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
ISSN journal
10400605 → ACNP
Volume
278
Issue
6
Year of publication
2000
Pages
L1273 - L1279
Database
ISI
SICI code
1040-0605(200006)278:6<L1273:HEITIP>2.0.ZU;2-X
Abstract
Somatic cell gene transfer is a potentially useful strategy to alter lung f unction. However, achieving efficient transfer to the alveolar epithelium, especially in smaller animals, has not been demonstrated. In this study, th e rat heme oxygenase-1 (HO-1) gene was delivered to the lungs of neonatal m ice via transpulmonary injection. A bidirectional promoter construct coexpr essing both HO-1 and a luciferase reporter gene was used so that in vivo ge ne expression patterns could be monitored in real time. HO-1 expression lev els were also modulated with doxycycline and assessed in vivo with biolumin escent light transmitted through the tissues from the coregulated luciferas e reporter. As a model of oxidative stress and HO-1-mediated protection, gr oups of animals were exposed to hyperoxia. After gene transfer, elevated le vels of HO-1 were detected predominantly in alveolar type II cells by immun ocytochemistry. With overexpression of HO-1, increased oxidative injury was observed. Furthermore, this model demonstrated a cell-specific effect of l ung HO-1 overexpression in oxidative stress. Specific control of expression for therapeutic genes is possible in vivo. The transpulmonary approach may prove useful in targeting gene expression to cells of the alveolar epithel ium or to circumscribed areas of the lung.